GOLM1 and hepatocellular carcinoma: Initially, GOLPH2 upregulation was reported in neoplastic and non-neoplastic liver pathologies, and a number of studies postulated its serum level as a novel marker of hepatocellular carcinoma [2,3,4,5,6,7,8].